1. Home
  2. CVAC vs MLP Comparison

CVAC vs MLP Comparison

Compare CVAC & MLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • MLP
  • Stock Information
  • Founded
  • CVAC 2000
  • MLP 1909
  • Country
  • CVAC Germany
  • MLP United States
  • Employees
  • CVAC N/A
  • MLP N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • MLP Real Estate
  • Sector
  • CVAC Health Care
  • MLP Finance
  • Exchange
  • CVAC Nasdaq
  • MLP Nasdaq
  • Market Cap
  • CVAC 764.4M
  • MLP 344.7M
  • IPO Year
  • CVAC 2020
  • MLP 1972
  • Fundamental
  • Price
  • CVAC $5.45
  • MLP $17.37
  • Analyst Decision
  • CVAC Hold
  • MLP
  • Analyst Count
  • CVAC 3
  • MLP 0
  • Target Price
  • CVAC $6.83
  • MLP N/A
  • AVG Volume (30 Days)
  • CVAC 2.3M
  • MLP 22.6K
  • Earning Date
  • CVAC 08-14-2025
  • MLP 08-18-2025
  • Dividend Yield
  • CVAC N/A
  • MLP N/A
  • EPS Growth
  • CVAC N/A
  • MLP N/A
  • EPS
  • CVAC 0.87
  • MLP N/A
  • Revenue
  • CVAC $566,039,775.00
  • MLP $14,886,000.00
  • Revenue This Year
  • CVAC N/A
  • MLP N/A
  • Revenue Next Year
  • CVAC $24.04
  • MLP N/A
  • P/E Ratio
  • CVAC $6.31
  • MLP N/A
  • Revenue Growth
  • CVAC 787.60
  • MLP 57.13
  • 52 Week Low
  • CVAC $2.37
  • MLP $14.05
  • 52 Week High
  • CVAC $5.72
  • MLP $26.46
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 63.45
  • MLP 48.98
  • Support Level
  • CVAC $5.36
  • MLP $17.72
  • Resistance Level
  • CVAC $5.51
  • MLP $18.58
  • Average True Range (ATR)
  • CVAC 0.07
  • MLP 0.77
  • MACD
  • CVAC -0.05
  • MLP -0.08
  • Stochastic Oscillator
  • CVAC 66.67
  • MLP 35.80

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About MLP Maui Land & Pineapple Company Inc.

Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales which includes land planning and entitlement, development, and sales activities; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.

Share on Social Networks: